RESEARCH
WILLIAM LENDERKING, PhD
In my thirty four year research career I and various colleagues published more than 80 papers, the most pertinent of which to my current practice in depression, anxiety, and memory impairment are cited below.
Development and initial validation of a brief mental health outcome measure
Read Here...
​
This was a scale we developed to measure general psychological functioning, in other words, to go beyond symptoms of individual disorders.
Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase
Read Here...
​
This was a scale developed to measure the early stages of memory impairment based on extensive interviews with normally aging adults, people with mild cognitive impairment, and people with early Alzheimer's disease.
Reliability, validity, and interpretation of the dependence scale in mild to moderately severe Alzheimer's disease
Read Here...
​
Using the dependence scale to understand the need for institutionalization for people with moderate Alzheimer's disease.
Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders
Read Here...
​
My very first publication, on the topic of mindfulness, meditation, and the treatment of anxiety.
Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexant
Read Here...
​
A scale on sleep disorder, a common problem for patients with anxiety and depression.
Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale
Read Here...
​
Development of a scale to measure cognitive function in a complex patient population.
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants
Read Here...
​
Rapid acting anti-depressants have become more widely used, this paper was a review of scales used to measure the benefits of these therapies.
Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) Tool
Read Here...
​​
Research in the clinical meaningfulness of a widely used Alzheimers measurement scale. ​